SciDevL (SDV) AGM 2024 Presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2024 Presentation summary
13 Jun, 2025Financial performance
Revenue reached $109.2 million in FY24, marking a 22% increase year-on-year.
EBITDA rose 117% to $8.8 million, with operating cash flow up 35% to $6.5 million.
Net profit after tax improved to $2.2 million from a $0.1 million loss in FY23.
Free cash flow before business acquisition was $3.3 million, and earnings per share rose to 1.15cps.
Consistent year-on-year growth in revenue, EBITDA, and operating cash flow since FY22.
Segment and operational highlights
Water Technologies business grew 88% in FY24, driven by domestic market penetration and higher contract values.
Chemical Services segment achieved 11% revenue growth.
Incorporated Nuoer SciDev JV in Singapore to expand MaxiFlox® chemistry in global mining.
55% increase in sales of CatChek™ technology in the US Oil & Gas market.
Developed FluorofIX™ pilot plants in Europe and North America to showcase technology performance.
Strategic focus and growth drivers
Emphasis on proprietary technology acceptance and disciplined capital management.
Water growth supported by new projects and larger contracts, with investment in resources to sustain expansion.
Diversified portfolio targets water treatment, specialty chemistries, PFAS remediation, and industrial water processes.
Addressable markets include industrial, government, oil & gas, mining, and infrastructure sectors.
Strategy centers on technology/R&D, operational excellence, capital management, and M&A.
Latest events from SciDevL
- Revenue and EBITDA declined, but recurring revenue and cost actions support future growth.SDV
H1 202625 Feb 2026 - EBITDA rose to $3.4m on steady $49.9m revenue, with strong cash and PFAS-driven growth outlook.SDV
H1 202526 Dec 2025 - $103m revenue, margin gains, and global PFAS growth set up strong FY 2026 outlook.SDV
H2 202523 Nov 2025 - Revenue and EBITDA surged, with strategic US wins and strong demand despite market volatility.SDV
Q3 2025 TU16 Jun 2025 - Q1 FY25 saw 21% revenue growth, 286% EBITDA increase, and robust cash flow.SDV
Q1 2025 TU13 Jun 2025 - Record revenue, profit, and cash flow position SciDev for continued growth in FY25.SDV
H2 202413 Jun 2025 - Record revenue and EBITDA growth driven by PFAS demand and major contract wins.SDV
Q4 2024 TU13 Jun 2025